GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
C

Cochlear COH.AX · AUD

Health Care · ASX · 🇦🇺 Australia

Compare

152.00

-2.23%

Close of 9 Nov 2026, in AUD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in AUD, from our data supplier.

FY2026

Revenue

A$2.33bn

FY2017FY2026

Net income

A$147.3m

FY2017FY2026

Free cash flow

A$306.9m

FY2017FY2026

Shareholders' equity

A$1.74bn

FY2017FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
RevenueA$2.33bnA$2.34bnA$2.24bnA$1.94bnA$1.64bnA$1.49bnA$1.35bnA$1.43bnA$1.36bnA$1.25bn
Gross profitA$1.65bnA$1.73bnA$1.67bnA$1.47bnA$1.23bnA$1.08bnA$1.01bnA$1.08bnA$1.00bnA$895.4m
Research and developmentA$323.2mA$291.5mA$277.0mA$244.9mA$210.7mA$195.0mA$185.1mA$184.4mA$167.7mA$151.9m
Operating incomeA$301.0mA$406.1mA$521.5mA$389.5mA$367.9mA$336.3mA$259.0mA$357.4mA$345.2mA$315.2m
Net incomeA$147.3mA$388.9mA$356.8mA$300.6mA$289.1mA$326.5m−A$238.3mA$276.7mA$245.8mA$223.6m
Diluted earnings per share2.255.935.444.574.404.96-3.634.794.263.88

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Total assetsA$2.60bnA$2.83bnA$2.75bnA$2.57bnA$2.47bnA$2.43bnA$2.58bnA$1.38bnA$1.16bnA$1.14bn
Cash and short-term investmentsA$187.7mA$275.7mA$513.6mA$555.5mA$629.3mA$609.6mA$930.0mA$78.6mA$61.5mA$89.5m
Total liabilitiesA$862.4mA$874.7mA$904.6mA$819.9mA$779.4mA$736.5mA$1.18bnA$653.3mA$546.1mA$592.7m
Debt—A$235.7mA$243.7mA$201.8mA$253.9mA$264.3mA$704.5mA$181.6mA$147.7mA$218.9m
Shareholders' equityA$1.74bnA$1.95bnA$1.84bnA$1.75bnA$1.69bnA$1.69bnA$1.40bnA$725.9mA$610.8mA$543.6m
Shares outstanding65m66m66m66m66m66m66m58m58m58m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operationsA$368.0mA$237.6mA$388.8mA$362.4mA$376.5mA$265.4m−A$157.8mA$296.0mA$258.1mA$259.8m
Capital spending−A$61.1m−A$62.4m−A$62.4m−A$95.9m−A$77.2m−A$66.7m−A$130.5m−A$59.9m−A$28.4m−A$53.5m
Free cash flowA$306.9mA$175.2mA$326.4mA$266.5mA$299.3mA$198.7m−A$288.3mA$236.1mA$229.7mA$206.3m
Dividends paid−A$281.2m−A$278.2m−A$245.7m−A$197.4m−A$194.0m−A$75.6m−A$193.7m−A$181.8m−A$161.1m−A$143.5m

Latest quarters

By quarter end

Jun 2026Dec 2025Jun 2025Mar 2025Dec 2024Jun 2024Dec 2023Jun 2023
RevenueA$1.16bnA$1.18bnA$1.19bnA$389.5mA$1.17bnA$1.14bnA$1.11bnA$1.06bn
Gross profitA$789.9mA$856.8mA$868.2mA$290.3mA$874.3mA$868.5mA$827.6mA$802.0m
Operating incomeA$80.2mA$220.8mA$251.2mA$63.4mA$274.6mA$253.2mA$268.3mA$218.2m
Net income−A$14.2mA$161.5mA$183.8mA$28.4mA$205.1mA$165.4mA$191.4mA$159.0m
Diluted earnings per share-0.222.462.800.433.132.522.912.42
Cash from operationsA$231.0mA$136.0mA$127.0m—A$109.0mA$231.0mA$157.0mA$273.0m
Capital spending−A$33.0m−A$28.0m−A$35.0m—−A$27.0m−A$39.0m−A$22.0m−A$53.0m
Free cash flowA$198.0mA$108.0mA$92.0m—A$82.0mA$192.0mA$135.0mA$220.0m
Total assetsA$2.60bnA$2.79bnA$2.83bn—A$2.79bnA$2.75bnA$2.53bnA$2.57bn
Cash and short-term investmentsA$187.7mA$187.1mA$275.7m—A$383.1mA$513.6mA$485.2mA$555.5m
DebtA$42.0mA$242.2mA$235.7m—A$246.6mA$243.7mA$206.7mA$201.8m
Shareholders' equityA$1.74bnA$1.94bnA$1.95bn—A$1.87bnA$1.84bnA$1.78bnA$1.75bn

Financial ratios

Data as of 4 Oct 2026

FY2026FY2025FY2024FY2023FY2022FY2021
Gross margin70.5%73.7%74.9%75.8%75.0%72.5%
Operating margin12.9%17.3%23.3%20.1%22.4%22.5%
Net margin6.3%16.6%16.0%15.5%17.6%21.9%
Return on equity8.5%19.9%19.4%17.2%17.2%19.3%
Return on assets5.7%13.8%13.0%11.7%11.7%13.5%
Free cash flow yield5.2%3.7%5.5%5.6%5.5%4.0%
Revenue growth-0.4%4.8%15.5%18.0%9.9%10.4%
Earnings growth-62.1%9.0%18.7%4.0%-11.5%-237.0%
Current ratio2.15x2.35x2.30x2.36x2.52x3.06x
Debt to equity0.02x0.02x0.02x0.02x0.05x0.05x
Equity ratio66.9%69.0%67.0%68.1%68.4%69.6%
Interest coverage22.80x36.92x56.68x41.44x42.78x28.02x
R&D as a share of sales13.8%12.4%12.4%12.6%12.8%13.1%
Buybacks as a share of market value0.2%0.1%0.1%0.1%-0.0%-0.1%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue6.4%9.3%7.5%
Operating income-8.2%-2.2%1.4%
Net income-21.2%-14.7%-2.5%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin72.1%73.6%73.7%73.5%
Operating margin15.1%18.3%19.4%20.9%
Net margin11.5%13.5%15.1%13.5%

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Price to earnings67.726.131.638.727.525.8-30.927.824.126.1
Price to sales4.34.35.06.04.85.65.55.44.34.7

Dividends and splits

Per share, in the currency the company pays

Paid for 30 years. Last went ex-dividend on 21 Sept 2026.

FY2027FY2026FY2025FY2024FY2023FY2022FY2021FY2020
Paid in the year1.305.8665.7074.8753.4812.951.154.786

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.